Nivolumab vs Voxilaprevir

## Nivolumab vs Voxilaprevir: Overview

This comparison examines the pharmacological differences between **Nivolumab** and **Voxilaprevir**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Nivolumab — 27 days; Voxilaprevir — N/A.

## Chemical Properties

**Type**: Nivolumab — Antibody; Voxilaprevir — Small molecule.